TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Promega Biotech AB
Closing information (x1000 SEK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
96,974
|
87,854
|
83,253 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
13,294
|
12,611
|
6,754 |
EBITDA |
13,370
|
12,774
|
6,976 |
Total assets |
36,839
|
42,719
|
34,800 |
Current assets |
36,684
|
42,503
|
34,449 |
Current liabilities |
13,472
|
10,116
|
12,619 |
Equity capital |
20,344
|
29,928
|
20,024 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
55.2%
|
70.1%
|
57.5% |
Turnover per employee |
9,697
|
8,785
|
8,325 |
Profit as a percentage of turnover |
13.7%
|
14.4%
|
8.1% |
Return on assets (ROA) |
36.1%
|
29.5%
|
19.4% |
Current ratio |
272.3%
|
420.2%
|
273.0% |
Return on equity (ROE) |
65.3%
|
42.1%
|
33.7% |
Change turnover |
9,120
|
4,601
|
7,572 |
Change turnover % |
10%
|
6%
|
10% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.